// App-Quantinova.ai

3047 : Sensitization of prostate cancer to chemo-radiation by ribosomal protein S6 inhibition

Researchers

Presenter

  • Suleman S. Hussain

Principal Investigators

  • Carolina B. Livi

  • Nikos Papanikolaou

  • Daniel C. Chan

  • Rita Ghosh

  • Addanki P. Kumar

Medical Centers

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Agilent Technologies, Santa Clara, CA

  • University of Colorado Hospital, Aurora, CO

Locations

  • United States

Companies

  • Agilent Technologies

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • p53

  • Phosphorylated-mechanistic target of rapamycin

  • Proliferation marker protein Ki-67

  • Prostate specific antigen

  • Cyclin D1

  • Histone H2AX

  • Hypoxia-inducible factor-1

  • TNF receptor superfamily member 25

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved